生物科技公司Capricor Therapeutics Inc.(CAPR)暴涨534.75%,现因波动过大而触发临时停牌。消息面上,公司公布了其评估DMD(杜氏肌营养不良症)德拉米细胞疗法的3期HOPE-3试验的顶线结果,该试验达到了主要终点和关键的次要心脏终点。
生物科技公司Capricor Therapeutics Inc.(CAPR)暴涨534.75%,现因波动过大而触发临时停牌。消息面上,公司公布了其评估DMD(杜氏肌营养不良症)德拉米细胞疗法的3期HOPE-3试验的顶线结果,该试验达到了主要终点和关键的次要心脏终点。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.